Insider Trading Activity Amyris Biotechnologies (NASDAQ:AMRS) – Mauritius) Pte Ltd Maxwell (Major Shareholder Sold 95,162 shares of Stock

ME Staff
-
0

Insider Trading Activity For Amyris Biotechnologies (NASDAQ:AMRS)

, Mauritius) Pte Ltd Maxwell (Major Shareholder of Amyris Biotechnologies (NASDAQ:AMRS) reportedly Sold 95,162 shares of the company’s stock at an average price of 6.54 for a total transaction amount of $622,359.48 SEC Form

Insider Trading History For Amyris Biotechnologies (NASDAQ:AMRS)

  • On 8/31/2012 L John Doerr, Director, bought 270,270 with an average share price of $3.70 per share and the total transaction amounting to $999,999.00.
  • On 8/31/2012 John Melo, CEO, sold 668,730 with an average share price of $3.70 per share and the total transaction amounting to $2,474,301.00.
  • On 12/24/2012 Thani Sheikh Abdullah Bin K Al, Director, bought 3,355,704 with an average share price of $2.98 per share and the total transaction amounting to $9,999,997.92.
  • On 3/27/2013 Thani Sheikh Abdullah Bin K Al, Director, bought 1,533,742 with an average share price of $3.26 per share and the total transaction amounting to $4,999,998.92.
  • On 5/24/2013 John Melo, CEO, sold 24,402 with an average share price of $2.85 per share and the total transaction amounting to $69,545.70.
  • On 5/15/2014 L John Doerr, Director, bought 172,186 with an average share price of $3.02 per share and the total transaction amounting to $520,001.72.
  • On 5/12/2015 John Melo, CEO, sold 65,575 with an average share price of $2.08 per share and the total transaction amounting to $136,396.00.

    • Analyst Ratings History For Amyris Biotechnologies (NASDAQ:AMRS)

    • On 9/28/2016 Singular Research Reiterated Rating Buy with a price target of $42.00
    • On 1/11/2017 Rodman & Renshaw Reiterated Rating Buy with a price target of $60.00
    • On 11/29/2017 Cowen Reiterated Rating Hold with a price target of $4.00
    • On 3/20/2018 B. Riley Set Price Target of rating Buy ➝ Buy with a price target of $8.00 ➝ $10.00
    • On 4/2/2018 HC Wainwright Reiterated Rating Buy with a price target of $15.00

    Recent Trading Activity for Amyris Biotechnologies (NASDAQ:AMRS)
    Shares of Amyris Biotechnologies closed the previous trading session at with shares trading hands.